Surrozen (SRZN) closed the second and final tranche of its March 2025 private placement, generating approximately $95.1 million in gross proceeds before fees and offering expenses. The closing followed FDA clearance of the investigational new drug application for SZN-8141 on October 2, 2026.
The company said its cash, cash equivalents and marketable securities are expected to fund operations into 2029, including the DUET Phase 1b/2a study of SZN-8141 and initial Phase 1b development of SZN-8143.
- The tranche included approximately 5.7 million common shares, pre-funded warrants for about 2.5 million shares, and Series E warrants for about 4.1 million shares.
- Series E warrants have an exercise price of $11.54 per share.
- Surrozen reported approximately 17.8 million common shares outstanding following the closing.
- First patient dosing in the DUET study is expected in the fourth quarter of 2026, with initial data anticipated in the second half of 2027.
$SRZNW Hedge Fund Activity
We have seen 2 institutional investors add shares of $SRZNW stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VIRTU FINANCIAL LLC removed 11,071 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $182
- UBS GROUP AG added 533 shares (+19.7%) to their portfolio in Q2 2026, for an estimated $8
- CLEAR STREET GROUP INC. added 200 shares (+200.0%) to their portfolio in Q2 2026, for an estimated $3
- ARROWMARK COLORADO HOLDINGS LLC added 0 shares (+0.0%) to their portfolio in Q2 2026, for an estimated $0
- ECOR1 CAPITAL, LLC added 0 shares (+0.0%) to their portfolio in Q2 2026, for an estimated $0
- PRICE T ROWE ASSOCIATES INC /MD/ added 0 shares (+0.0%) to their portfolio in Q2 2026, for an estimated $0
- LMR PARTNERS LLP added 0 shares (+0.0%) to their portfolio in Q2 2026, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.